04:38 AM EST, 03/03/2025 (MT Newswires) -- Qiagen ( QGEN ) said Monday it filed a patent infringement complaint in Germany against bioMerieux to protect its QuantiFERON technology for tuberculosis diagnostics.

The complaint is related to European Patent EP 2 276 883 B2, the company said.

bioMerieux did not immediately reply to MT Newswires' request for comment.